Danisco US, Inc v. Novozymes A/S
3:12-cv-04502
Overview
Parties
Defendant
Novozymes A/S NPE (Individual / Inventor)
Represented By
3 Attorneys ListedFenwick and West
1191 Second Ave., 10th Floor, Seattle, WA 98101
Ewa M. Davison
1191 Second Ave., 10th Floor, Seattle, WA 98101
Virginia K DeMarchi
555 Washington Ave., Palo Alto, CA 94301
Novozymes North America, Inc. Operating Company
Represented By
3 Attorneys ListedFenwick and West
1191 Second Ave., 10th Floor, Seattle, WA 98101
Ewa M. Davison
1191 Second Ave., 10th Floor, Seattle, WA 98101
Virginia K DeMarchi
555 Washington Ave., Palo Alto, CA 94301
Plaintiff
Danisco US, Inc Operating Company
Represented By
4 Attorneys ListedGibson Dunn and Crutcher LLP
2100 McKinney Ave., Suite 1100, Dallas, TX 75201
Vinson and Elkins LLP
2801 via Fortuna, Suite 100, Austin, TX 78746
Gibson Dunn and Crutcher LLP
2100 McKinney Ave., Suite 1100, Dallas, TX 75201
Counter-Claimant
Novozymes A/S NPE (Individual / Inventor)
Represented By
3 Attorneys ListedFenwick and West
1191 Second Ave., 10th Floor, Seattle, WA 98101
Ewa M. Davison
1191 Second Ave., 10th Floor, Seattle, WA 98101
Virginia K DeMarchi
555 Washington Ave., Palo Alto, CA 94301
Novozymes North America, Inc. Operating Company
Represented By
3 Attorneys ListedFenwick and West
1191 Second Ave., 10th Floor, Seattle, WA 98101
Ewa M. Davison
1191 Second Ave., 10th Floor, Seattle, WA 98101
Virginia K DeMarchi
555 Washington Ave., Palo Alto, CA 94301
Counter Defendant
Danisco US, Inc Operating Company
Represented By
4 Attorneys ListedGibson Dunn and Crutcher LLP
2100 McKinney Ave., Suite 1100, Dallas, TX 75201
Vinson and Elkins LLP
2801 via Fortuna, Suite 100, Austin, TX 78746
Gibson Dunn and Crutcher LLP
2100 McKinney Ave., Suite 1100, Dallas, TX 75201
Court & Judges
Court
District Court, N.D. California (cand)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 17 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8252573
Alpha-amylase variant with altered properties
|
Filed: 2011-02-03
Issued: 2012-08-28
|
Active (4.2 yrs remaining)
Expires: 2031-02-03
|
|
|
US8084240
Geobacillus stearothermophilus α-amylase (AmyS) variants with improved properties
|
Filed: 2009-06-02
Issued: 2011-12-27
|
Active (3.3 yrs remaining)
+267d PTA
Expires: 2030-02-24
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
13
Dispositive
8
Granted
2
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings